Stock A950130 ACCESS BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Access Bio, Inc.

Equities

A950130

KR8840090003

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-16 EDT 		5-day change 1st Jan Change
7,430 KRW -2.49% Intraday chart for Access Bio, Inc. +6.75% -17.17%
2023 Access Bio, Inc. acquired an unknown minority stake in CuraPatient Inc. CI
2023 Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 114,803 67,553 784,363 569,632 414,360 302,841
Enterprise Value (EV) 1 147,953 97,510 781,283 439,381 -8,933 29,006
P/E ratio -26 x -3.34 x 15.8 x 3.12 x 1.32 x -95.5 x
Yield - - - - 6.75% -
Capitalization / Revenue 2.85 x 1.57 x 6.44 x 1.13 x 0.4 x 0.87 x
EV / Revenue 3.68 x 2.26 x 6.41 x 0.87 x -0.01 x 0.08 x
EV / EBITDA -105 x -10.9 x 11.2 x 1.65 x -0.02 x 0.77 x
EV / FCF -14.7 x 52 x 36.1 x 3.95 x -0.03 x 19.2 x
FCF Yield -6.83% 1.92% 2.77% 25.3% -3,300% 5.2%
Price to Book 3.49 x 2.75 x 9.38 x 1.99 x 0.67 x 0.52 x
Nbr of stocks (in thousands) 26,792 32,793 35,572 35,602 33,964 33,762
Reference price 2 4,285 2,060 22,050 16,000 12,200 8,970
Announcement Date 19-03-20 20-03-18 21-03-16 22-03-22 23-03-20 24-03-18
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 40,239 43,059 121,797 505,112 1,033,863 348,643
EBITDA 1 -1,407 -8,981 69,950 265,733 479,065 37,882
EBIT 1 -4,479 -12,401 66,536 259,669 468,238 21,922
Operating Margin -11.13% -28.8% 54.63% 51.41% 45.29% 6.29%
Earnings before Tax (EBT) 1 -6,140 -21,611 62,479 256,760 463,696 -5,879
Net income 1 -4,241 -17,588 48,272 189,690 346,670 -3,173
Net margin -10.54% -40.85% 39.63% 37.55% 33.53% -0.91%
EPS 2 -165.0 -616.5 1,392 5,127 9,212 -93.91
Free Cash Flow 1 -10,098 1,875 21,620 111,287 294,780 1,508
FCF margin -25.09% 4.35% 17.75% 22.03% 28.51% 0.43%
FCF Conversion (EBITDA) - - 30.91% 41.88% 61.53% 3.98%
FCF Conversion (Net income) - - 44.79% 58.67% 85.03% -
Dividend per Share - - - - 823.0 -
Announcement Date 19-03-20 20-03-18 21-03-16 22-03-22 23-03-20 24-03-18
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 33,149 29,957 - - - -
Net Cash position 1 - - 3,080 130,251 423,293 273,835
Leverage (Debt/EBITDA) -23.56 x -3.336 x - - - -
Free Cash Flow 1 -10,098 1,875 21,620 111,287 294,780 1,508
ROE (net income / shareholders' equity) -13.1% -57.9% 83.5% 101% 76.4% -0.87%
ROA (Net income/ Total Assets) -2.97% -9.42% 34.7% 53% 44.1% 1.74%
Assets 1 142,561 186,728 139,248 357,769 786,268 -182,557
Book Value Per Share 2 1,228 749.0 2,352 8,050 18,199 17,277
Cash Flow per Share 2 169.0 208.0 1,382 5,592 13,932 8,210
Capex 1 1,668 3,053 10,385 34,079 18,753 18,615
Capex / Sales 4.15% 7.09% 8.53% 6.75% 1.81% 5.34%
Announcement Date 19-03-20 20-03-18 21-03-16 22-03-22 23-03-20 24-03-18
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Diagnostic & Testing Substances

1st Jan change Capi.
ACCESS BIO, INC. Stock Access Bio, Inc.
-17.17% 186M
BIOMÉRIEUX Stock bioMérieux
-4.67% 12.32B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-5.19% 8.07B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+9.45% 5.92B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+28.50% 5.52B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-8.09% 4.21B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-55.31% 2.99B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+13.49% 2.73B
VITROLIFE AB Stock Vitrolife AB
-1.34% 2.43B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+32.24% 2.29B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. A950130 Stock
  4. Financials Access Bio, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW